Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

FGF9 from certain T cells helps create new hair follicles during wound healing, which could potentially be used for hair loss treatments.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

A parasite molecule can speed up skin healing and reduce scarring.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Elagolix did not effectively treat polycystic ovary syndrome.

Excessive iodine from a cystic fibrosis supplement can cause hypothyroidism.

Sex hormones affect liver fat and metabolic health differently in men and women.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

High TNF-α levels may increase hair loss risk after PRP therapy.

Reactive lipids from aging cells change the extracellular matrix, affecting cell function and inflammation.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

HGF/SF injections can stimulate hair growth and increase hair follicle size in mice.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Ch55 may help reduce skin scarring and fibrosis.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Platelet-released growth factors can reduce inflammation in joint disease.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

GLI2 increases follistatin production in human skin cells.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.